Earlier Cancer Detection.
Improving healthcare.

Read More

About Us

Clinical Genomics develops innovative products for colorectal cancer diagnosis. With a broad intellectual property portfolio including more than 20 patents, Clinical Genomics delivers products to improve early cancer detection. Our user-friendly, patient-preferred colorectal cancer screening InSure® FIT™ test is available worldwide and has been used to screen more than 10 million people.

Clinical Genomics is investing in technologies and clinical research that deliver better options to healthcare practitioners and lead to improved clinical outcomes for patients.

Clinical Genomics has developed a genomic blood test to diagnose colorectal cancer at the earliest, most treatable stages.

Learn More